296 related articles for article (PubMed ID: 36837560)
21. Radiofrequency ablation for the management of pancreatic mass lesions.
Merchant AA; Goebel AM; Willingham FF
Curr Opin Gastroenterol; 2023 Sep; 39(5):448-454. PubMed ID: 37097824
[TBL] [Abstract][Full Text] [Related]
22. Utility of Contrast-Enhanced Harmonic Endoscopic Ultrasound for the Guidance and Monitoring of Endoscopic Radiofrequency Ablation.
Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
Gut Liver; 2020 Nov; 14(6):826-832. PubMed ID: 32000466
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.
El Sayed G; Frim L; Franklin J; McCrudden R; Gordon C; Al-Shamma S; Kiss S; Hegyi P; Erőss B; Hegyi PJ
Therap Adv Gastroenterol; 2021; 14():17562848211042171. PubMed ID: 34819995
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic Ultrasound-Guided Radiofrequency Ablation of the Pancreatic Tumors: A Promising Tool in Management of Pancreatic Tumors.
Changela K; Patil R; Duddempudi S; Gaduputi V
Can J Gastroenterol Hepatol; 2016; 2016():4189358. PubMed ID: 27478820
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic microcystic serous cystic neoplasms: a retrospective study.
Oh D; Ko SW; Seo DW; Hong SM; Kim JH; Song TJ; Park DH; Lee SK; Kim MH
Endoscopy; 2021 Jul; 53(7):739-743. PubMed ID: 33063298
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic ultrasound-guided radiofrequency ablation of unresectable pancreatic cancer with low ablation power and multiple applications: a preliminary study of 11 patients.
Wang J; Wang Y; Zhao Y; Wu X; Zhang M; Hou W; Chen Q; Cheng B
Ann Palliat Med; 2021 Feb; 10(2):1842-1850. PubMed ID: 33440967
[TBL] [Abstract][Full Text] [Related]
27. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Garg R; Mohammed A; Singh A; Harnegie MP; Rustagi T; Stevens T; Chahal P
Endosc Ultrasound; 2022; 11(3):170-185. PubMed ID: 35313416
[TBL] [Abstract][Full Text] [Related]
28. An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management.
Elkelany OO; Karaisz FG; Davies B; Krishna SG
Curr Oncol; 2023 Aug; 30(8):7566-7580. PubMed ID: 37623030
[TBL] [Abstract][Full Text] [Related]
29. Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms.
Rimbaş M; Horumbă M; Rizzatti G; Crinò SF; Gasbarrini A; Costamagna G; Larghi A
Dig Endosc; 2020 Nov; 32(7):1031-1041. PubMed ID: 31995848
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ultrasound-guided ethanol ablation therapy for tumors.
Zhang WY; Li ZS; Jin ZD
World J Gastroenterol; 2013 Jun; 19(22):3397-403. PubMed ID: 23801831
[TBL] [Abstract][Full Text] [Related]
31. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature.
Imperatore N; de Nucci G; Mandelli ED; de Leone A; Zito FP; Lombardi G; Manes G
Endosc Int Open; 2020 Dec; 8(12):E1759-E1764. PubMed ID: 33269308
[No Abstract] [Full Text] [Related]
33. Endoscopic ultrasonography-guided tumor ablation.
Lakhtakia S; Seo DW
Dig Endosc; 2017 May; 29(4):486-494. PubMed ID: 28171697
[TBL] [Abstract][Full Text] [Related]
34. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos).
Lakhtakia S; Ramchandani M; Galasso D; Gupta R; Venugopal S; Kalpala R; Reddy DN
Gastrointest Endosc; 2016 Jan; 83(1):234-9. PubMed ID: 26394384
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
[TBL] [Abstract][Full Text] [Related]
36. EUS-RFA of the pancreas: where are we and future directions.
Gollapudi LA; Tyberg A
Transl Gastroenterol Hepatol; 2022; 7():18. PubMed ID: 35548478
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series.
de Nucci G; Imperatore N; Mandelli ED; di Nuovo F; d'Urbano C; Manes G
Endosc Int Open; 2020 Dec; 8(12):E1754-E1758. PubMed ID: 33269307
[No Abstract] [Full Text] [Related]
38. Endoscopic Ultrasound-Guided Antegrade Radiofrequency Ablation and Metal Stenting With Hepaticoenterostomy for Malignant Biliary Obstruction: A Prospective Preliminary Study.
Inoue T; Ibusuki M; Kitano R; Kobayashi Y; Ohashi T; Sumida Y; Nakade Y; Ito K; Yoneda M
Clin Transl Gastroenterol; 2020 Oct; 11(10):e00250. PubMed ID: 33108126
[TBL] [Abstract][Full Text] [Related]
39. Endosonography-guided Radiofrequency Ablation in Pancreatic Diseases: Time to Fill the Gap Between Evidence and Enthusiasm.
Vanella G; Capurso G; Arcidiacono PG
J Clin Gastroenterol; 2020 Aug; 54(7):591-601. PubMed ID: 32482951
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of endoscopic ultrasound-guided ablation and minimally invasive surgery in the treatment of pancreatic insulinoma: a systematic review and meta-analysis.
Xiao D; Zhu L; Xiong S; Yan X; Jiang Q; Wang A; Jia Y
Front Endocrinol (Lausanne); 2024; 15():1367068. PubMed ID: 38645424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
